Rehydra+ Wellness Tirzepatide Review: The $169 Is a Six-Month Contract (2026)

Rehydra+ Wellness advertises compounded tirzepatide from $169 a month. You cannot buy a month. Every GLP-1 membership it sells is a six-month agreement, described on the site itself as non-cancelable, so the smallest tirzepatide membership you can enter is $1,014, and the largest is $2,514. That sentence is the review; everything below is the evidence for it. This page carries no outbound link; every figure below came out of the site's own product API in August 2026.

What "from $169/month" actually costs

The phrase on both the membership page and each product page is the same: valid for six months, non-cancelable. Two independent surfaces, identical wording, no small print softening it. So the monthly figures are not prices in the sense a reader uses the word — they are an installment schedule on a purchase you have already made and cannot unmake.

This matters more for tirzepatide than for almost any other drug, because the reason people leave a GLP-1 in the first ninety days is that they cannot tolerate it. Nausea, vomiting and diarrhea are front-loaded during titration; gallbladder events and pancreatitis are labeled risks; a minority of people simply do not respond. Our guides to how long tirzepatide side effects last and the gallbladder risk exist because those exits are common. A six-month non-cancelable contract prices that exit at whatever you have left to pay.

There is a cancellable way to buy, and it is not the membership

Rehydra+ also sells tirzepatide as one-time supply packs. These are ordinary purchases — you buy a quantity of drug, you are not enrolled in anything, and there is nothing to cancel. Four weeks of tirzepatide runs $219 at 2.5 mg, $249 at 5 mg, $319 at 7.5 mg, $449 at 10 mg, $629 at 12.5 mg and $649 at 15 mg.¹ Eight- and twelve-week packs cost more in total and less per week, and 10 mg and 12.5 mg have no twelve-week pack at all.

Read those numbers against the memberships and the structure gets clearer. A four-week pack at the starting dose is $219 against an advertised "$169 a month" — so the membership discount is real, and it is what you are being paid to sign a six-month contract for. At 15 mg, four weeks costs $649, which is $230 more than the top membership tier's monthly rate. If you want to try tirzepatide from this company without committing $1,014, the supply pack is the only door. Note that "duration" here is supply length, not a billing cadence: a twelve-week pack is a quantity of drug, not three months of care.

What it does not tell you

No pharmacy is named. The site refers to "our pharmacy partner" and never says who that is. For a compounded product, the compounder is the single most load-bearing fact about what is in the vial, and it is withheld.

The twenty states are never listed. The about page says the company serves patients in twenty states. No page names them. The state names that do appear on the site belong to a checkout dropdown containing all fifty, which is a form control, not a coverage list.

The certification badge cannot be checked. The site claims third-party pharmacy certification and displays a badge for it — but the badge is a JPEG hosted on Rehydra+'s own server, linking to a keyword search rather than to a certificate. The certifier publishes verifiable seal images with per-company identifiers; there is no such identifier anywhere on this site. That makes the claim unverified, not false — we could not confirm it either way, and we are not going to imply we disproved it.

No NPIs. Three clinicians are named — John H. Hamilton, MD as medical director, Angie Tuzson, NP and Jared Folwell, MD — which is more than many. None has a published NPI, so none of the registrations can be checked. The Edit publishes one that resolves; this is what the same disclosure looks like without the checkable part.

The corporate entity is given as RealHealth Ventures PLLS, trading as Rehydra+ Wellness, at a residential-format address in San Antonio, Texas. "PLLS" is how the site spells it. We are recording it verbatim rather than correcting it to PLLC on the company's behalf.

The rest of the catalog is a separate problem

Twenty-three products, and several of them do not belong on a page next to a prescription GLP-1. Testosterone is sold as an ordinary cart item. The peptide line includes oral BPC-157, oral KPV and oral tesamorelin — peptides sold as swallowed products, a route whose bioavailability for these molecules is not established.

None of that changes what tirzepatide costs here. It does change what kind of company is dispensing it, and it is the reason we would not treat a clean tirzepatide transaction as evidence about anything else on the shelf.

Payment, financing and refunds

This is a shopping cart, not an intake. You pay at checkout, before a provider reviews you, and the refund policy does not clearly address what happens if you are turned down. Once a prescription ships there are no returns and no refunds. Financing is offered through a buy-now-pay-later provider, with a 2.99% processing fee on credit-card down payments disclosed on the payment-plan page and nowhere else.

Stack those together: you pay first, you are reviewed after, the medication is non-returnable, and the membership you may have just entered runs six months and cannot be canceled.

The regulatory screen

To be clear about what this review is not saying: the brand name and the legal entity both returned zero company-column matches in the FDA's live warning-letter index in August 2026.² The screen carried a positive control that correctly returned a real February 2026 letter to an unrelated telehealth seller every time,³ so the zero is evidence. Rehydra+ has no FDA warning letter. Our objection is to its contract terms and its disclosure, not its enforcement record.

Brand versus compounded

Compounded tirzepatide, not Zepbound — pharmacy-made, not an FDA-approved finished drug, and not the product the trials tested. See is compounded tirzepatide still legal in 2026. The molecule itself performs: roughly 15% to 21% average body-weight loss over 72 weeks in SURMOUNT-1⁴, about 20% versus 14% against semaglutide in SURMOUNT-5⁵. Our tirzepatide evidence guide has the detail, and it belongs to the brand product at approved doses.

The honest verdict

We do not file a monthly price for Rehydra+ Wellness, because it does not sell one. What it sells is a six-month non-cancelable agreement quoted in monthly installments, and a range of one-time supply packs that are honestly priced and genuinely cancellable because there is nothing to cancel. If you buy here, buy a supply pack. A four-week pack at $219 to $649 depending on dose is a real transaction with a real exit, and it lets you find out whether you tolerate tirzepatide before anyone has $1,014 of your money. If you want a monthly tirzepatide plan you can actually stop, Trellis Vitality is $199 with no commitment and Auren Rx is $299, and both name their terms plainly. Compare the whole field in our tirzepatide price index or the ranked best tirzepatide providers ranking.